Shunsuke Yamamoto

7PUBLICATIONS
26CO-AUTHORS
Molecular targetsPharmaceutical delivery technologiesRespiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 06, 2025
Access Program for Unapproved and Off-Label Drug Use in Pediatric BRAF V600E-Mutated Brain Tumors in Japan.

Maya Suzuki, Yuhki Koga, Terumi Kawasaki

|Jan 01, 2024
Thrombospondin-1 is an endogenous substrate of cereblon responsible for immunomodulatory drug-induced thromboembolism.

Kiwamu Hatakeyama, Yoshikane Kikushige, Daisuke Ishihara

|Aug 23, 2022
A preterm newborn-onset juvenile myelomonocytic leukemia-like myeloproliferation with PTPN11 mutation.

Shunsuke Yamamoto, Shingo Nakao, Hirosuke Inoue

Pageof 2